These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26988293)

  • 1. Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.
    Vistarop AG; Cohen M; De Matteo E; Preciado MV; Chabay PA
    Sci Rep; 2016 Mar; 6():23303. PubMed ID: 26988293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
    Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
    Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.
    Hudnall SD; Ge Y; Wei L; Yang NP; Wang HQ; Chen T
    Mod Pathol; 2005 Apr; 18(4):519-27. PubMed ID: 15696119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive EBV infection characteristics in children from a developing country.
    Ferressini Gerpe NM; Vistarop AG; Moyano A; De Matteo E; Preciado MV; Chabay PA
    Int J Infect Dis; 2020 Apr; 93():139-145. PubMed ID: 32004689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils.
    Joseph AM; Babcock GJ; Thorley-Lawson DA
    J Virol; 2000 Nov; 74(21):9964-71. PubMed ID: 11024124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
    Araujo I; Foss HD; Hummel M; Anagnostopoulos I; Barbosa HS; Bittencourt A; Stein H
    J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between local immune response and Epstein-Barr virus-infected tonsillar cells could lead to viral infection control.
    Vistarop AG; Cohen M; Huaman F; Irazu L; Rodriguez M; De Matteo E; Preciado MV; Chabay PA
    Med Microbiol Immunol; 2018 Nov; 207(5-6):319-327. PubMed ID: 30046954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of Epstein-Barr virus and human adenovirus small RNAs in tonsillar B and T lymphocytes.
    Assadian F; Kamel W; Laurell G; Svensson C; Punga T; Akusjärvi G
    PLoS One; 2017; 12(5):e0177275. PubMed ID: 28542273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
    Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
    Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus colonization of tonsillar and peripheral blood B-cell subsets in primary infection and persistence.
    Chaganti S; Heath EM; Bergler W; Kuo M; Buettner M; Niedobitek G; Rickinson AB; Bell AI
    Blood; 2009 Jun; 113(25):6372-81. PubMed ID: 19351961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue markers of Epstein-Bar virus (EBV) infection in B-cell non-Hodgkin's lymphomas.
    Kasprzak A; Spachacz R; Hałoń A; Jeleń M; Stefańska K; Wachowiak J; Trejster E; Zabel M
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):639-48. PubMed ID: 17317895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) association and latency profile in pediatric Burkitt's lymphoma: experience of a single institution in Argentina.
    Lara J; Cohen M; De Matteo E; Aversa L; Preciado MV; Chabay P
    J Med Virol; 2014 May; 86(5):845-50. PubMed ID: 24027016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjects.
    Kwok H; Chan KW; Chan KH; Chiang AK
    PLoS One; 2015; 10(3):e0120710. PubMed ID: 25807555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection in paediatric liver transplant recipients: detection of the virus in post-transplant tonsillectomy specimens.
    Meru N; Davison S; Whitehead L; Jung A; Mutimer D; Rooney N; Kelly D; Niedobitek G
    Mol Pathol; 2001 Aug; 54(4):264-9. PubMed ID: 11477143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
    Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
    J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.
    Liao Y; Yan J; Beri NR; Giulino-Roth L; Cesarman E; Gewurz BE
    PLoS Pathog; 2024 Apr; 20(4):e1011939. PubMed ID: 38683861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
    Longnecker R
    Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
    Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.